Tag Archives: Afatinib

Afatinib (BIBW 2992*) Triples Progression Free Survival in Lung Cancer Patients

Afatinib (BIBW 2992*) Triples Progression Free Survival in Lung Cancer Patients Boehringer Ingelheim announced promising results from two clinical trials of its investigational cancer compound afatinib (BIBW 2992) presented at the 35th European Society for Medical Oncology (ESMO) Congress in … Continue reading

Posted in Lung Cancer | Tagged , , , , , , , , , | Leave a comment